drugset / Trial / NCT00306111

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

NCT00306111

Phase 2 Completed 14 enrolled University Hospital Tuebingen
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the ability of pegfilgrastim vs. filgrastim to mobilize peripheral blood stem cells in patients with Non Hodgkin-lymphoma in an intraindividual study

Timeline

Start
2006-01
Primary completion
2008-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pegfilgrastim Protein / enzyme biologic 6 mg

Indications